These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35507210)

  • 1. Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores.
    Al-Sha'er MA; Basheer HA; Taha MO
    Mol Divers; 2023 Feb; 27(1):443-462. PubMed ID: 35507210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.
    Tuffaha GO; Hatmal MM; Taha MO
    J Mol Graph Model; 2019 Sep; 91():30-51. PubMed ID: 31158642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore modeling of JAK1: A target infested with activity-cliffs.
    Daoud S; Taha MO
    J Mol Graph Model; 2020 Sep; 99():107615. PubMed ID: 32339898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods.
    Abutayeh RF; Taha MO
    J Mol Graph Model; 2019 May; 88():128-151. PubMed ID: 30703688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR-guided pharmacophoric modeling reveals important structural requirements for Polo kinase 1 (Plk1) inhibitors.
    Shahin R; Al-Hashimi NN; Daoud NE; Aljamal S; Shaheen O
    J Mol Graph Model; 2021 Dec; 109():108022. PubMed ID: 34562852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of New Phosphoinositide 3-kinase Delta (PI3Kδ) Inhibitors via Virtual Screening using Crystallography-derived Pharmacophore Modelling and QSAR Analysis.
    Al-Sha'er MA; Al-Aqtash RA; Taha MO
    Med Chem; 2019; 15(6):588-601. PubMed ID: 30799792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.
    Shahin R; Swellmeen L; Shaheen O; Aboalhaija N; Habash M
    J Comput Aided Mol Des; 2016 Jan; 30(1):39-68. PubMed ID: 26685860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH; Zihlif MA; Taha MO
    Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Potent Bruton's Tyrosine Kinase Inhibitors Using Ligand Based Modeling.
    Mera WA; Alzihlif M; Taha MO; Khanfar MA
    Anticancer Agents Med Chem; 2017; 17(2):265-275. PubMed ID: 27671297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor.
    Al-Sha'er MA; Taha MO
    J Mol Graph Model; 2018 Aug; 83():153-166. PubMed ID: 29456101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Binding Characteristics of Phosphoinositide-dependent Kinase-1 (PDK1) Co-crystallized Ligands Through Virtual Pharmacophore Modeling Leading to Novel Anti-PDK1 Hits.
    Mansi IA; Al-Sha'er MA; Mhaidat NM; Taha MO; Shahin R
    Med Chem; 2020; 16(7):860-880. PubMed ID: 31339076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads.
    Al-Aqtash RA; Zihlif MA; Hammad H; Nassar ZD; Meliti JA; Taha MO
    Comput Biol Chem; 2017 Dec; 71():170-179. PubMed ID: 29101826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study.
    Mousa LA; Hatmal MM; Taha M
    J Comput Aided Mol Des; 2022 Jan; 36(1):39-62. PubMed ID: 35059939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elaboration of Novel TTK1 Inhibitory Leads via QSAR-Guided Selection of Crystallographic Pharmacophores Followed By In Vitro Assay.
    Al-Sha'er MA; Taha MO
    Curr Comput Aided Drug Des; 2021; 17(4):511-522. PubMed ID: 32525782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling.
    Zalloum H; Tayyem R; Irmaileh BA; Bustanji Y; Zihlif M; Mohammad M; Rjai TA; Mubarak MS
    J Mol Graph Model; 2015 Sep; 61():61-84. PubMed ID: 26188796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA).
    Hijjawi MS; Abutayeh RF; Taha MO
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents.
    Mansi I; Al-Sha'er MA; Mhaidat N; Taha M
    Anticancer Agents Med Chem; 2020; 20(4):476-485. PubMed ID: 31889497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors.
    Khanfar MA; Taha MO
    J Mol Recognit; 2017 Sep; 30(9):. PubMed ID: 28299833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening.
    Al-Sha'er MA; Almazari IS; Taha MO
    J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28008665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.